| Company | Designation | Period |
|---|---|---|
| Johnson & Johnson | Global TMO - Application Services | Sep 2012 – Mar 2014 |
| Vanavil Dyes & Chemicals Limited - Colour Chem | Management Trainee | Jun 1999 – May 2000 |
| Archimedis Healthcare Private Limited | Director - Quality & International Business | Jul 2014 – Aug 2018 |
| UBS | Infosys Function Lead - D & EL Risk QA | Jan 2005 – Jan 2006 |
| Belgacom Mobile | Onsite Coordinator - E2E Team (PNI Regression Testing) | Jan 2003 – Jan 2004 |
| Deloitte | Vice President - Product Management | Aug 2018 – Apr 2021 |
| Infosys Technologies Limited | Manager - Client Solutions | Aug 2000 – Feb 2008 |
| Archimedis Healthcare | President & CEO | Apr 2021 – Mar 2023 |
| Archimedis Digital | Founder & CEO | May 2022 – Present |
Estimated Range: ₹0 – ₹1000+ Cr (approx. $0 – $120M+)
Based on publicly accessible filings, industry benchmarks, and leadership compensation patterns.
Official Email: Via Archimedis Digital corporate communication desk.
Personal Contact: Not publicly disclosed.
What is Duraisamy Palani's net worth?
Estimated ₹0 – ₹1000+ Cr (approx. $0 – $120M+).
How can I contact them?
Through Archimedis Digital's official communication channels.
Is this an official profile?
No — independently created using public data.
This profile is created for general informational purposes. All details are based on publicly accessible information and independent research. While accuracy is prioritized, content may not always reflect the latest updates.
Nothing here should be interpreted as investment, financial, or legal advice. The individual featured has not authored or endorsed this profile.
Personal information is intentionally withheld. For official matters, please use formal communication channels associated with the respective organization.
Affluense AI – Smarter Insights. Stronger Relationships with Affluents.
Last Updated: December 2025 · Published by Affluense AI (affluense.ai)